Darwin Biotech reports early ALS functional and NfL signals from randomised Phase 1 ALT001 study
Darwin Biotech reports early ALT001 functional and NfL signals in ALS, with a US trial planned to test higher doses and longer treatment.
Pharma & Biotech
Medical Devices & Diagnostics
Gemelli Biotech highlights 85-patient study linking intestinal sulfide overproduction to distinct gene-expression changes
Gemelli Biotech highlights research linking intestinal sulfide overproduction to distinct gut gene activity, supporting further study of Trio-Smart.
Pharma & Biotech
Avenzo Therapeutics to present first ORION-1 Phase 1 data for selective CDK4 inhibitor AVZO-023
Avenzo will present first ORION-1 data for AVZO-023 in December, testing whether selective CDK4 inhibition offers a better tolerability profile.
Medical Devices & Diagnostics
SetPoint Medical completes first Boston implant of FDA-approved rheumatoid arthritis neurostimulation system
SetPoint Medical completes its first Boston RA implant, expanding access to FDA-approved vagus nerve therapy after positive RESET-RA results.
Pharma & Biotech
TransCode Therapeutics has advanced TTX-MC138 into Phase 2a, so why is it exploring a sale or strategic partnership?
TransCode appoints Tungsten Advisors to explore TTX-MC138 licensing and sale options as its ctDNA-positive colorectal cancer trial advances.
Pharma & Biotech
Can Ascletis ASC30 compete with established oral GLP-1 treatments?
Ascletis reports up to 1.7-point HbA1c reduction and 4.4% weight loss with oral ASC30, as larger trials must confirm safety and efficacy.
Pharma & Biotech
Preservative-free ketamine gets FDA approval as NRx Pharmaceuticals targets US hospital supply
NRx Pharmaceuticals secures FDA approval for preservative-free ketamine. Discover what it means for drug shortages and domestic manufacturing.
Features & Analysis
Sabirnetug trial failure forces Acumen Pharmaceuticals to reassess Alzheimer’s drug development strategy
Acumen Pharmaceuticals halts sabirnetug after its Phase 2 Alzheimer's trial fails despite amyloid reduction. Discover what the findings mean.
Medical Devices & Diagnostics
Edison Scientific signs Pfizer agreement to deploy Kosmos AI scientist across pharmaceutical R&D
Edison Scientific partners with Pfizer to deploy Kosmos across drug R&D, testing whether AI can turn decades of research data into better decisions.
Medical Devices & Diagnostics
HSG has taken control of PeierTech, but why is medical-grade nitinol attracting private equity investment?
HSG acquires approximately 80% of PeierTech, targeting global growth in nitinol materials, precision components and medical device manufacturing.